ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Accounts Payable
ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Accounts Payable of $33.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $32.32M, a 1514.54% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.34M, a 29.43% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$10.84M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.65M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for fiscal 2025 was -$5.29M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for fiscal 2024 was -$1.35M, a 128.16% decline from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for fiscal 2023 was $4.80M, a 18.28% decline from fiscal 2022.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts payable for fiscal 2022 was $5.87M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $32.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $33.67M 10-Q · filed 2026-08-05 | $22.82M derived: sum of 3 quarters · filed 2026-08-05 | $24.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-07 | -$9.50M derived: sum of 2 quarters · filed 2026-05-07 | -$7.85M derived: sum of 3 quarters · filed 2026-05-07 | -$5.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.19M derived: sum of 2 quarters · filed 2026-02-26 | -$7.19M derived: sum of 3 quarters · filed 2026-08-05 | -$5.29M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.65M derived: sum of 2 quarters · filed 2026-08-05 | $5.55M 10-Q · filed 2025-11-06 | $2.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.90M 10-Q · filed 2026-08-05 | $1.02M derived: sum of 3 quarters · filed 2026-08-05 | $215.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.90M 10-Q · filed 2026-05-07 | -$986.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.79M derived: sum of 3 quarters · filed 2026-05-07 | -$1.24M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.69M derived: sum of 2 quarters · filed 2026-02-26 | -$3.14M derived: sum of 3 quarters · filed 2026-02-26 | -$1.35M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$251.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.54M 10-Q · filed 2025-11-06 | $6.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.34M 10-Q · filed 2025-08-07 | $7.57M derived: sum of 3 quarters · filed 2026-02-26 | $1.07M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.79M 10-Q · filed 2025-05-08 | $7.02M derived: sum of 2 quarters · filed 2026-02-26 | $521.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.91M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.27M derived: sum of 2 quarters · filed 2026-02-26 | $121.00K derived: sum of 3 quarters · filed 2026-02-26 | $4.80M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$5.11M derived: sum of 2 quarters · filed 2024-11-07 | -$436.00K 10-Q · filed 2024-11-07 | $2.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.07M 10-Q · filed 2024-08-07 | $8.80M derived: sum of 3 quarters · filed 2025-02-27 | $6.96M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.68M 10-Q · filed 2024-05-09 | $7.41M derived: sum of 2 quarters · filed 2025-02-27 | $5.57M derived: sum of 3 quarters · filed 2025-02-27 | $6.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $892.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.98M derived: sum of 3 quarters · filed 2025-02-27 | $5.87M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$760.00K derived: sum of 2 quarters · filed 2023-11-03 | $3.13M 10-Q · filed 2023-11-03 | $2.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.98M 10-Q · filed 2023-08-03 | $4.13M derived: sum of 3 quarters · filed 2024-02-28 | $2.79M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $3.89M 10-Q · filed 2023-05-08 | $3.05M derived: sum of 2 quarters · filed 2024-02-28 | $1.70M derived: sum of 3 quarters · filed 2024-02-28 | $1.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$846.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.19M derived: sum of 2 quarters · filed 2024-02-28 | -$1.97M derived: sum of 3 quarters · filed 2024-02-28 | -$1.62M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.13M derived: sum of 2 quarters · filed 2022-11-03 | -$771.00K 10-Q · filed 2022-11-03 | $4.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $572.00K 10-Q · filed 2022-08-09 | $5.59M derived: sum of 3 quarters · filed 2023-02-28 | $2.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $356.00K 10-Q · filed 2022-05-05 | $5.38M derived: sum of 2 quarters · filed 2023-02-28 | $2.38M derived: sum of 3 quarters · filed 2023-02-28 | $2.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.03M derived: sum of 2 quarters · filed 2023-02-28 | $1.87M derived: sum of 3 quarters · filed 2023-02-28 | $1.27M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$3.15M derived: sum of 2 quarters · filed 2021-11-09 | -$3.75M 10-Q · filed 2021-11-09 | $27.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$756.00K 10-Q · filed 2021-08-05 | $3.02M derived: sum of 3 quarters · filed 2022-03-01 | $1.82M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$599.00K 10-Q · filed 2021-05-06 | $3.18M derived: sum of 2 quarters · filed 2022-03-01 | $1.97M derived: sum of 3 quarters · filed 2022-03-01 | $3.35M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.57M derived: sum of 2 quarters · filed 2022-03-01 | $3.95M derived: sum of 3 quarters · filed 2022-03-01 | $4.05M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $169.00K derived: sum of 2 quarters · filed 2020-11-04 | $277.00K 10-Q · filed 2020-11-04 | $514.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.48M 10-Q · filed 2020-08-06 | $1.72M derived: sum of 3 quarters · filed 2021-02-25 | $1.39M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $108.00K 10-Q · filed 2020-05-08 | $345.00K derived: sum of 2 quarters · filed 2021-02-25 | $12.00K derived: sum of 3 quarters · filed 2021-02-25 | $279.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$96.00K derived: sum of 2 quarters · filed 2021-02-25 | $171.00K derived: sum of 3 quarters · filed 2021-02-25 | -$5.62M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$66.00K derived: sum of 2 quarters · filed 2019-10-31 | -$5.86M 10-Q · filed 2019-10-31 | -$32.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$5.52M 10-Q · filed 2019-08-01 | $301.00K derived: sum of 3 quarters · filed 2020-02-27 | -$325.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$5.79M 10-Q · filed 2019-05-02 | $34.00K derived: sum of 2 quarters · filed 2020-02-27 | -$592.00K derived: sum of 3 quarters · filed 2020-02-27 | $983.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.20M derived: sum of 2 quarters · filed 2020-02-27 | $6.77M derived: sum of 3 quarters · filed 2020-02-27 | $4.87M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$626.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $949.00K derived: sum of 2 quarters · filed 2018-11-06 | -$950.00K 10-Q · filed 2018-11-06 | $296.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$324.00K 10-Q · filed 2018-08-08 | $922.00K derived: sum of 3 quarters · filed 2019-02-27 | $2.56M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$1.90M 10-Q · filed 2018-05-04 | -$653.00K derived: sum of 2 quarters · filed 2019-02-27 | $989.00K derived: sum of 3 quarters · filed 2019-02-27 | $706.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.89M derived: sum of 2 quarters · filed 2019-02-27 | $2.60M derived: sum of 3 quarters · filed 2019-02-27 | $2.24M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.36M derived: sum of 2 quarters · filed 2017-11-07 | $994.00K 10-Q · filed 2017-11-07 | $506.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$648.00K 10-Q · filed 2017-08-08 | -$1.14M derived: sum of 3 quarters · filed 2018-02-27 | -$1.89M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$365.00K 10-Q · filed 2017-05-09 | -$853.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.61M derived: sum of 3 quarters · filed 2018-02-27 | -$1.12M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.24M derived: sum of 2 quarters · filed 2018-02-27 | -$752.00K derived: sum of 3 quarters · filed 2018-02-27 | -$344.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$264.00K derived: sum of 2 quarters · filed 2016-11-07 | $144.00K 10-Q · filed 2016-11-07 | $1.05M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $492.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $900.00K 10-Q · filed 2016-08-04 | $1.81M derived: sum of 3 quarters · filed 2017-02-28 | $1.81M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $408.00K 10-Q · filed 2016-05-05 | $1.31M derived: sum of 2 quarters · filed 2017-02-28 | $1.32M derived: sum of 3 quarters · filed 2017-02-28 | $862.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $906.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $912.00K derived: sum of 2 quarters · filed 2017-02-28 | $454.00K derived: sum of 3 quarters · filed 2017-02-28 | $1.64M 10-K · filed 2017-02-28 |
| 2014-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$452.00K derived: sum of 2 quarters · filed 2015-11-05 | $738.00K 10-Q · filed 2015-11-05 | -$10.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $732.00K 10-Q · filed 2015-08-06 | -$16.00K derived: sum of 3 quarters · filed 2016-02-29 | -$73.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.19M 10-Q · filed 2015-05-07 | $442.00K derived: sum of 2 quarters · filed 2016-02-29 | $385.00K derived: sum of 3 quarters · filed 2016-02-29 | $166.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$805.00K derived: sum of 2 quarters · filed 2016-02-29 | -$1.02M derived: sum of 3 quarters · filed 2016-02-29 | -$1.00M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$276.00K derived: sum of 2 quarters · filed 2014-11-10 | -$255.00K 10-Q · filed 2014-11-10 | -$11.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$198.00K 10-Q · filed 2014-08-05 | $46.00K derived: sum of 3 quarters · filed 2015-02-26 | $420.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $21.00K 10-Q · filed 2014-05-06 | $265.00K derived: sum of 2 quarters · filed 2015-02-26 | $639.00K derived: sum of 3 quarters · filed 2015-02-26 | $362.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $618.00K derived: sum of 2 quarters · filed 2015-02-26 | $341.00K derived: sum of 3 quarters · filed 2015-02-26 | -$585.00K 10-K · filed 2015-02-26 |
| 2012-09-30 | $374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $97.00K derived: sum of 2 quarters · filed 2013-11-06 | -$829.00K 10-Q · filed 2013-11-06 | -$130.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$1.20M 10-Q · filed 2013-08-06 | -$504.00K derived: sum of 3 quarters · filed 2014-02-27 | -$381.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$926.00K 10-Q · filed 2013-05-07 | -$227.00K derived: sum of 2 quarters · filed 2014-02-27 | -$104.00K derived: sum of 3 quarters · filed 2014-02-27 | -$353.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $699.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $822.00K derived: sum of 2 quarters · filed 2014-02-27 | $573.00K derived: sum of 3 quarters · filed 2014-02-27 | -$29.00K 10-K · filed 2014-02-27 |
| 2011-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$126.00K derived: sum of 2 quarters · filed 2012-11-05 | -$728.00K 10-Q · filed 2012-11-05 | -$1.36M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$851.00K 10-Q · filed 2012-08-08 | -$1.49M derived: sum of 3 quarters · filed 2013-03-12 | -$1.21M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | -$602.00K 10-Q · filed 2012-05-08 | -$1.24M derived: sum of 2 quarters · filed 2013-03-12 | -$959.00K derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$357.00K derived: sum of 2 quarters · filed 2013-03-12 | -$990.00K 10-K · filed 2013-03-12 | |
| 2010-09-30 | $280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$353.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$633.00K 10-Q · filed 2011-08-10 | |||
| 2009-12-31 | $656.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |